HiFiBiO
Sami Ellouze has a diverse background and extensive experience in the field of biotechnology. They have held a variety of positions at different companies, with a focus on single cell science, antibody drug discovery, and CRISPR/CAS9 technology implementation. With a strong educational background in biological engineering and NGS, they have demonstrated expertise in research and project management throughout their career.
This person is not in any offices
HiFiBiO
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiBiO Therapeutics aspires to benefit patients through open-innovation partnerships with industry and academia.